Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

AIM OF THE STUDY: The majority of patients with chronic myeloid leukaemia (CML) respond to tyrosine kinase inhibitors (TKI), while allogeneic haematopoietic cell transplantation (HCT) is indicated in selected clinical situations. HCT carries the risk of severe complications, while the toxicity profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Piekarska, Agnieszka, Gil, Lidia, Jakitowicz, Karolina, Prejzner, Witold, Komarnicki, Mieczysław, Hellmann, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371710/
https://www.ncbi.nlm.nih.gov/pubmed/28373825
http://dx.doi.org/10.5114/wo.2016.64607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371710/
https://www.ncbi.nlm.nih.gov/pubmed/28373825
http://dx.doi.org/10.5114/wo.2016.64607

Ejemplares similares